:: CLDF ::

Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver Transplantation

Cancers (Basel). 2020 Nov 14;12(11):E3372. doi: 10.3390/cancers12113372.

Dimitrios Moris¹, Brian I Shaw¹, Lisa McElroy¹, Andrew S Barbas¹

Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic

Curr Oncol. 2020 Oct;27(5):e501-e511. doi: 10.3747/co.27.6785. Epub 2020 Oct 1.

S Bennett¹, K Søreide², S Gholami³, P Pessaux⁴, C Teh⁵, E Segelov⁶, H Kennecke³, H Prenen⁷, S Myrehaug¹, D Callegaro^1 8, J Hallet¹

A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival

J Hepatol. 2020 Nov 11;S0168-8278(20)33750-8. doi: 10.1016/j.jhep.2020.10.033.Online ahead of print.

Neil Mehta¹, Jennifer L Dodge², John P Roberts², Francis Y Yao³

Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation

Metallomics. 2020 Nov 4. doi: 10.1039/d0mt00156b. Online ahead of print.

Caroline I Davis¹, Xingxing Gu², Ryan M Kiefer³, Martina Ralle⁴, Terence P Gade⁵, Donita C Brady⁶

ACR Appropriateness Criteria® Liver Lesion-Initial Characterization

Am Coll Radiol. 2020 Nov;17(11S):S429-S446.doi: 10.1016/j.jacr.2020.09.005.

Expert Panel on Gastrointestinal Imaging; Victoria Chernyak¹, Jeanne M Horowitz², Ihab R Kamel³, Hina Arif-Tiwari⁴, Mustafa R Bashir⁵, Brooks D Cash⁶, James Farrell⁷, Alan Goldstein⁸, Joseph R Grajo⁹, Samir Gupta¹⁰, Nicole M Hindman¹¹, Aya Kamaya¹², Michelle M McNamara¹³, Kristin K Porter¹³, Lilja Bjork Solnes¹⁴, Pavan K Srivastava¹⁵, Atif Zaheer¹⁶, Laura R Carucci¹⁷

A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials

Expert Rev Anticancer Ther. 2020 Nov 2. doi: 10.1080/14737140.2021.1842204.Online ahead of print.

Richard F Pollock¹, Victoria K Brennan², Suki Shergill², Fabien Colaone²

Patients with hepatocellular carcinoma from more rural and lower income households have more advanced tumor stage at diagnosis and significantly higher mortality

Cancer. 2020 Oct 26. doi: 10.1002/cncr.33211. Online ahead of print.

Robert J Wong^1 2, Donghee Kim², Aijaz Ahmed², Ashwani K Singal³

New advances in the diagnosis and management of hepatocellular carcinoma

BMJ. 2020 Oct 26;371:m3544. doi: 10.1136/bmj.m3544.

Ju Dong Yang^1 2 3, Julie K Heimbach⁴

Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans

Implement Sci. 2020 Oct 21;15(1):92. doi: 10.1186/s13012-020-01050-7.

Shari S Rogal^1 2, Vera Yakovchenko³, Timothy Morgan^4 5, Jasmohan S Bajaj^6 7, Rachel Gonzalez⁸, Angela Park⁹, Lauren Beste^10 11, Edward J Miech¹², Carolyn Lamorte¹³, Brittney Neely¹³, Sandra Gibson¹³, Patrick S Malone¹⁴, Maggie Chartier¹⁵, Tamar Taddei^16 17, Guadalupe Garcia-Tsao^16 17, Byron J Powell¹⁸, Jason A Dominitz^19 20, David Ross¹⁵, Matthew J Chinman^13 21

10.

Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma

Clin Liver Dis. 2020 Nov;24(4):549-576. doi: 10.1016/j.cld.2020.06.002.Epub 2020 Aug 25.

Tracey G Simon¹, Andrew T Chan²

11.

Role of Biomarkers and Biopsy in Hepatocellular Carcinoma

Clin Liver Dis. 2020 Nov;24(4):577-590. doi: 10.1016/j.cld.2020.07.001.Epub 2020 Aug 28.

Vincent L Chen¹, Pratima Sharma²

12.

Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine

Clin Liver Dis. 2020 Nov;24(4):591-610. doi: 10.1016/j.cld.2020.07.010.Epub 2020 Sep 3

Monika Vyas¹, Xuchen Zhang²

13.

The Changing Global Epidemiology of Hepatocellular Carcinoma

Clin Liver Dis. 2020 Nov;24(4):535-547. doi: 10.1016/j.cld.2020.06.001.Epub 2020 Aug 16.

Allyce Caines¹, Ranya Selim², Reena Salgia²

14.

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial

Thomas Yau¹, Yoon-Koo Kang², Tae-You Kim³, Anthony B El-Khoueiry⁴, Armando Santoro⁵, Bruno Sangro⁶, Ignacio Melero⁷, Masatoshi Kudo⁸, Ming-Mo Hou⁹, Ana Matilla¹⁰, Francesco Tovoli¹¹, Jennifer J Knox¹², Aiwu Ruth He¹³, Bassel F El-Rayes¹⁴, Mirelis Acosta-Rivera¹⁵, Ho-Yeong Lim¹⁶, Jaclyn Neely¹⁷, Yun Shen¹⁸, Tami Wisniewski¹⁹, Jeffrey Anderson¹⁹, Chiun Hsu²⁰

15.

Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation

Health Technol Assess. 2020 Sep;24(48):1-264. doi: 10.3310/hta24480.

Matthew Walton¹, Ros Wade¹, Lindsay Claxton¹, Sahar Sharif-Hurst¹, Melissa Harden¹, Jai Patel², Ian Rowe², Robert Hodgson¹, Alison Eastwood¹

16.

Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis

Hepatol Commun. 2020 Jul 6;4(9):1332-1345. doi: 10.1002/hep4.1518. eCollection 2020 Sep.

Surain B Roberts^1 2, Marwa Ismail¹, Gowthami Kanagalingam¹, Andrew L Mason³, Mark G Swain⁴, Catherine Vincent⁵, Eric M Yoshida⁶, Cynthia Tsien⁷, Jennifer A Flemming⁸, Harry L A Janssen¹, Gideon M Hirschfield¹, Bettina E Hansen^1 2, Aliya F Gulamhusein^1 2, Canadian Network for Autoimmune Liver Disease

17.

Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France

Cardiovasc Intervent Radiol. 2020 Sep 25. doi: 10.1007/s00270-020-02643-x.Online ahead of print.

Romaric Loffroy¹, Maxime Ronot², Michel Greget³, Antoine Bouvier⁴, Charles Mastier⁵, Christian Sengel⁶, Lambros Tselikas⁷, Dirk Arnold⁸, Geert Maleux⁹, Jean-Pierre Pelage¹⁰, Olivier Pellerin¹¹, Bora Peynircioglu¹², Bruno Sangro¹³, Niklaus Schaefer¹⁴, María Urdániz¹⁵, Nathalie Kaufmann¹⁶, José Ignacio Bilbao¹⁷, Thomas Helmberger¹⁸, Valérie Vilgrain², CIRT-FR Principal Investigators

Collaborators

CIRT-FR Principal Investigators:

Gilles Piana, Julien Frandon, Jean-Pierre Tasu, Hicham Kobeiter

18.

Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study

Ann Surg Oncol. 2020 Sep 25. doi: 10.1245/s10434-020-09156-4. Online ahead of print.

Joshua P Kronenfeld¹, Emily L Ryon¹, David Goldberg², Rachel M Lee³, Adam Yopp⁴, Annie Wang⁵, Ann Y Lee⁵, Sommer Luu⁶, Cary Hsu⁶, Eric Silberfein⁶, Maria C Russell³, Alan S Livingstone¹, Nipun B Merchant¹, Neha Goel⁷

19.

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma

Cancers (Basel). 2020 Sep 23;12(10):E2730. doi: 10.3390/cancers12102730.

Kelly Regan-Fendt¹, Ding Li^2 3, Ryan Reyes⁴, Lianbo Yu¹, Nissar A Wani⁵, Peng Hu^2 3, Samson T Jacob⁴, Kalpana Ghoshal^2 3, Philip R O Payne⁶, Tasneem Motiwala¹

20.

A mixed-methods approach to understanding perceptions of hepatitis B and hepatocellular carcinoma among ethnically diverse Black communities in South Florida

Cancer Causes Control. 2020 Sep 22. doi: 10.1007/s10552-020-01345-6. Online ahead of print.

Patricia Jones^1 2, Joselin Soler³, Natasha Schaefer Solle^4 5, Paul Martin^3 4, Erin Kobetz^4 5 6

21.

Hepatitis B virus preS2?38-55 variants: A newly identified risk factor for hepatocellular carcinoma

JHEP Rep. 2020 Jul 11;2(5):100144. doi: 10.1016/j.jhepr.2020.100144. eCollection 2020 Oct.

Damien Cohen¹, Sumantra Ghosh¹, Yusuke Shimakawa², Njie Ramou³, Pierre Simon Garcia^4 5, Anaëlle Dubois¹, Clément Guillot¹, Nora Kakwata-Nkor Deluce¹, Valentin Tilloy⁶, Geoffroy Durand³, Catherine Voegele³, Gibril Ndow⁷, Umberto d'Alessandro⁷, Céline Brochier-Armanet⁴, Sophie Alain⁶, Florence Le Calvez-Kelm³, Janet Hall¹, Fabien Zoulim^1 8, Maimuna Mendy³, Mark Thursz⁹, Maud Lemoine⁹, Isabelle Chemin¹

22.

SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)

J Gastrointest Cancer. 2020 Sep 9. doi: 10.1007/s12029-020-00502-z. Online ahead of print.

Ryan D Hirsch^1 2, Chris Mills³, Rohit Sawhney^4 5, Siddharth Sood⁶, Virginia Bird⁶, Gauri Mishra⁷, Anouk Dev⁷, William Kemp^8 9, John Lubel^8 9, Stuart K Roberts^8 9, Paul Gow³, Amanda J Nicoll^4 5 6

23.

Liquid biopsy in the clinical management of hepatocellular carcinoma

Gut. 2020 Sep 3;gutjnl-2019-320282. doi: 10.1136/gutjnl-2019-320282.Online ahead of print.

Johann von Felden^# 1, Teresa Garcia-Lezana², Kornelius Schulze³, Bojan Losic⁴, Augusto Villanueva^# 5 6

24.

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

ESMO Open. 2020 Aug;5(4):e000714. doi: 10.1136/esmoopen-2020-000714.

Robin Kate Kelley¹, Baek-Yeol Ryoo², Philippe Merle³, Joong-Won Park⁴, Luigi Bolondi⁵, Stephen L Chan⁶, Ho Yeong Lim⁷, Ari D Baron⁸, Francis Parnis⁹, Jennifer Knox¹⁰, Stéphane Cattan¹¹, Thomas Yau¹², Julie C Lougheed¹³, Steven Milwee¹⁴, Anthony B El-Khoueiry¹⁵, Ann-Lii Cheng¹⁶, Tim Meyer¹⁷, Ghassan K Abou-Alfa^18 19

25.

Individualized adaptive radiation therapy allows for safe treatment of hepatocellular carcinoma in patients with Child-Turcotte-Pugh B liver disease

Int J Radiat Oncol Biol Phys. 2020 Aug 24;S0360-3016(20)34141-9.doi: 10.1016/j.ijrobp.2020.08.046. Online ahead of print.

William C Jackson¹, Ming Tang², Christopher Maurino², Mishal Mendiratta-Lala³, Neehar D Parikh⁴, Martha M Matuszak², Janell S Dow², Yue Cao², Charles S Mayo², Randall K Ten Haken², Matthew J Schipper², Kyle C Cuneo², Dawn Owen², Theodore S Lawrence²